Gastroenterology
Medicines

Gastroenterology Medicine Supply for Hospitals & International Buyers

Gastrointestinal disorders are among the most common reasons for hospital admission and specialist referral worldwide. In the GCC region and across Africa, the burden spans a broad range of conditions: gastro-oesophageal reflux disease (GORD) and peptic ulcer disease are highly prevalent in urban populations with changing dietary habits; inflammatory bowel disease (IBD) including Crohn's disease and ulcerative colitis is rising in incidence across the Gulf; liver disease related to non-alcoholic fatty liver disease, viral hepatitis and alcohol consumption affects millions across Africa; and irritable bowel syndrome (IBS) and functional GI disorders generate substantial outpatient demand. Euro Biom supplies gastroenterology medicines sourced from the UK pharmaceutical market to hospitals, GI units and international healthcare buyers across these regions.

Acid suppression is one of the highest-volume therapeutic areas in any hospital formulary. Euro Biom sources all five proton pump inhibitors available on the UK market: omeprazole, lansoprazole, pantoprazole, esomeprazole and rabeprazole, in oral capsule, dispersible tablet and intravenous formulations. H2 receptor antagonists, including famotidine, are available for patients where PPIs are not tolerated or where step-down therapy is required. Alginate-antacid combination preparations and standard antacid suspensions complete the acid-suppression portfolio.

For inflammatory bowel disease, Euro Biom supplies the full range of aminosalicylates: mesalazine in oral modified-release tablets, granules and rectal formulations (suppositories and enemas), and sulfasalazine tablets. Immunosuppressant maintenance therapy is covered with azathioprine tablets and mercaptopurine. Biologic therapy for IBD is a key area of international procurement demand; Euro Biom can source infliximab (originator and biosimilars), adalimumab, vedolizumab and ustekinumab for licensed GI units under appropriate named-patient or institutional supply arrangements.

Antiemetics, Bowel Preparations and Liver Medicines

Nausea and vomiting management is critical across oncology, post-operative and general medical settings. Euro Biom sources a comprehensive antiemetic range: ondansetron in oral and injectable formulations, metoclopramide, domperidone, prochlorperazine (tablets, buccal and injection), cyclizine and granisetron. Neurokinin-1 antagonists including aprepitant are available for chemotherapy-induced nausea. These cover the full range of antiemetic mechanisms required by GI, oncology and anaesthetic teams.

Bowel habit management medicines are in consistent demand across both primary and secondary care. Euro Biom supplies antidiarrhoeals including loperamide capsules and liquid, as well as oral rehydration preparations. The laxative range covers macrogol (polyethylene glycol) sachets in standard and high-dose bowel preparation strengths, lactulose solution, senna tablets, bisacodyl tablets and suppositories, and linaclotide capsules for IBS with constipation. Phosphate enemas and sodium picosulfate preparations for bowel cleansing before procedures are also available.

Liver and hepatic disease medicines form a distinct and clinically important segment of the gastroenterology range. Euro Biom sources ursodeoxycholic acid (UDCA) capsules and tablets for primary biliary cholangitis and cholestatic liver disease, rifaximin tablets for hepatic encephalopathy prevention and IBS-D, and lactulose solution for acute hepatic encephalopathy. For the management of complications of portal hypertension, terlipressin injection and spironolactone tablets for ascites management are available. These medicines are often difficult to source consistently in African and GCC markets and represent a significant proportion of named-patient import requests.

Helicobacter pylori eradication therapy is a core component of peptic ulcer management and gastric cancer prevention. Euro Biom supplies all components required for standard triple and quadruple eradication regimens: omeprazole or lansoprazole as the acid-suppressing backbone, combined with amoxicillin capsules, clarithromycin tablets, metronidazole tablets and bismuth subcitrate for bismuth-based quadruple therapy. Pre-packaged H. pylori eradication kits licensed in the UK are also available and are frequently requested by GCC hospital pharmacies seeking compliant combination packs.

GCC and African hospitals face specific procurement challenges in gastroenterology that UK supply addresses directly. IBD biologics including vedolizumab and ustekinumab may not be marketed locally or may be subject to supply disruptions; Euro Biom provides a reliable sourcing route under GDP-compliant conditions including cold chain management for temperature-sensitive biologics. Shortage situations affecting individual GI medicines occur periodically in regional markets; Euro Biom's UK WDA licence and established manufacturer relationships allow rapid response to urgent hospital requirements. Contact us with your gastroenterology product requirements and our team will respond within one business day with availability and pricing.